DCGI gives EUA to India’s first nasal vaccine against COVID-19 Press Information Bureau Sep 7, 2022 BBV154 is an intra-nasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine
Nigeria introduces Bharat Biotech’s Rotavac vaccine for immunisation in children EP News Bureau Aug 25, 2022 Rotavirus infection causes about 50,000 child fatalities under the age of five each year in Nigeria
Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154… EP News Bureau Aug 16, 2022 Data from both phase-III human clinical trials have been submitted for approval to National Regulatory Authorities
Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine in August Press Trust of India Aug 2, 2022 The Drug Controller General of India (DCGI) gave its nod to conduct clinical trials for Bharat Biotech’s intranasal vaccine as…
Covaxin demonstrates persistence of immunity and impact of third dose of inactivated COVID-19… EP News Bureau Jul 20, 2022 Subjects were evaluated for safety, neutralising antibody responses against variants of concern, binding antibodies against spike…
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years EP News Bureau Jun 22, 2022 Ocugen’s partner Bharat Biotech’s phase-II/III study of Covaxin (BBV152) in 526 children showed safety, efficacy, and superior…
ICMR study finds Covaxin booster dose improves effectiveness against Delta, Omicron variants Press Trust of India Jun 15, 2022 The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed…
US FDA lifts hold on Covaxin’s clinical trials Press Trust of India May 25, 2022 The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a…
CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop… EP News Bureau May 11, 2022 CEPI will fund the researchers to conduct activities including immunogen design, pre-clinical studies, manufacturing process…
Bharat Biotech seeks DCGI nod for phase-II/III Covaxin booster trial Press Trust of India May 5, 2022 The study is likely to be conducted at six sites, including AIIMS Delhi and Patna